Researchers have developed a means of improving prognosis methods and predicting how long patients with myelodysplastic syndromes (MDS) will live after diagnosis by identifying certain gene mutations in their abnormal bone marrow.
Researchers have developed a means of improving prognosis methods and predicting how long patients with myelodysplastic syndromes (MDS) will live after diagnosis by identifying certain gene mutations in their abnormal bone marrow.